Literature DB >> 22841506

Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment.

Nobuyoshi Kosaka1, Fumitaka Takeshita, Yusuke Yoshioka, Keitaro Hagiwara, Takeshi Katsuda, Makiko Ono, Takahiro Ochiya.   

Abstract

MicroRNAs (miRNAs) act to fine-tune cellular responses in a variety of biological circumstances such as development, organogenesis, and homeostasis. The dysregulation of miRNA expression accelerates disease progression, including metabolic disease, immunological disease and cancer, through the gene network disorder. Therefore, understanding the miRNA maturation process may unravel the mechanisms of cancer malignancy; however, the life of miRNA has not been clarified. In this article, we summarize the recent findings regarding the novel forms of miRNA, especially secretory miRNAs, focusing on exosomal miRNAs. Recent research has revealed that exosomal miRNAs affect many aspects of physiological and pathological conditions, and may be useful as novel therapy. Here, we propose a method for the delivery of tumor-suppressive miRNAs to desired sites using exosomes, and we named this method "exocure".
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841506     DOI: 10.1016/j.addr.2012.07.011

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  28 in total

1.  Good things come in small packages: exosomes, immunity and cancer.

Authors:  W Wang; M T Lotze
Journal:  Cancer Gene Ther       Date:  2014-04       Impact factor: 5.987

Review 2.  Extracellular RNA mediates and marks cancer progression.

Authors:  Jasmina S Redzic; Leonora Balaj; Kristan E van der Vos; Xandra O Breakefield
Journal:  Semin Cancer Biol       Date:  2014-04-28       Impact factor: 15.707

Review 3.  Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.

Authors:  Chao Liu; Haiyan Gao; Peng Lv; Jingyi Liu; Gang Liu
Journal:  Hum Vaccin Immunother       Date:  2017-09-26       Impact factor: 3.452

Review 4.  MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.

Authors:  Luna Soley; Carolyne Falank; Michaela R Reagan
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 5.  Pancreatic cancer diagnosis by free and exosomal miRNA.

Authors:  Margot Zöller
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

Review 6.  Exosomal microRNAs in hepatocellular carcinoma.

Authors:  Chenbin Liu; Han Wu; Yinqi Mao; Wei Chen; Shuying Chen
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

7.  Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes.

Authors:  Ikuhiko Nakase; Shiroh Futaki
Journal:  Sci Rep       Date:  2015-05-26       Impact factor: 4.379

Review 8.  Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications.

Authors:  Julieta De Toro; Leticia Herschlik; Claudia Waldner; Claudia Mongini
Journal:  Front Immunol       Date:  2015-05-04       Impact factor: 7.561

Review 9.  Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles.

Authors:  Nao Nishida-Aoki; Takahiro Ochiya
Journal:  Cell Mol Life Sci       Date:  2015-01-07       Impact factor: 9.261

Review 10.  Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.

Authors:  J A Smith; T Leonardi; B Huang; N Iraci; B Vega; S Pluchino
Journal:  Biogerontology       Date:  2014-06-28       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.